Avidity Biosciences Inc. (RNA) Announces $100M Proposed Public Offering of Common Stock

Go back to Avidity Biosciences Inc. (RNA) Announces $100M Proposed Public Offering of Common Stock

Avidity Biosciences Inc. (RNA) Prices 8M Share Offering at $18/sh

August 4, 2021 5:30 AM EDT

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock at a price to the public of... More